Hisashi Noma Selected Research

TS 108

12/2017

SR-16234, a Novel Selective Estrogen Receptor Modulator for Pain Symptoms with Endometriosis: An Open-label Clinical Trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hisashi Noma Research Topics

Disease

3	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 01/2018
3	Critical Illness (Critically Ill) 09/2020 - 01/2017
3	Glaucoma 03/2020 - 09/2013
3	Type 2 Diabetes Mellitus (MODY) 01/2020 - 04/2018
3	Rectal Neoplasms (Rectal Cancer) 01/2018 - 10/2016
2	Osteoporosis 03/2022 - 09/2021
2	Asthma (Bronchial Asthma) 01/2020 - 10/2015
2	Myocardial Infarction 01/2020 - 12/2011
2	Pain (Aches) 01/2019 - 12/2017
2	Dysmenorrhea (Menstrual Pain) 01/2019 - 12/2017
2	Body Weight (Weight, Body) 01/2018 - 06/2014
2	Hypoglycemia (Reactive Hypoglycemia) 01/2017 - 01/2017
2	Bipolar Disorder (Manic Depressive Psychosis) 04/2016 - 10/2014
2	Ganglion Cysts (Ganglion) 08/2015 - 12/2014
2	Weight Gain 01/2015 - 01/2014
1	Periodontal Diseases (Periodontal Disease) 03/2022
1	Necrosis 03/2022
1	Gestational Weight Gain 01/2022
1	Fuchs' Endothelial Dystrophy 01/2022
1	Peritonitis 01/2022
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 11/2021
1	Metabolic Bone Diseases (Osteopenia) 09/2021
1	Breast Neoplasms (Breast Cancer) 01/2021
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2021
1	Chronic Renal Insufficiency 01/2021
1	Mediastinal Emphysema (Pneumomediastinum) 01/2021
1	Carotid Artery Diseases 11/2020
1	Rheumatoid Arthritis 11/2020
1	Atherosclerosis 11/2020
1	Inflammation (Inflammations) 11/2020
1	Limbal Stem Cell Deficiency 10/2020
1	Respiratory Tract Infections (Respiratory Tract Infection) 09/2020
1	Psoriasis (Pustulosis Palmaris et Plantaris) 07/2020
1	Hyperemia 03/2020
1	Eosinophilia 01/2020
1	Heart Diseases (Heart Disease) 01/2020
1	Insulin Resistance 01/2020
1	Mood Disorders (Mood Disorder) 01/2020
1	Connective Tissue Diseases (Connective Tissue Disease) 03/2019
1	Mixed Connective Tissue Disease (MCTD) 03/2019
1	Epilepsy (Aura) 01/2019
1	Major Depressive Disorder (Major Depressive Disorders) 01/2019
1	Stroke (Strokes) 01/2019
1	Low Back Pain (Lumbago) 01/2019
1	Abdominal Pain (Pain, Abdominal) 01/2019
1	Corneal Edema 01/2019
1	Vomiting 01/2019
1	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2019
1	Anhedonia 01/2019
1	Nausea 01/2019

Drug/Important Bio-Agent (IBA)

4	Pharmaceutical PreparationsIBA 03/2022 - 10/2014
3	Insulin (Novolin)FDA Link 01/2020 - 01/2017
3	Retinaldehyde (Retinal)IBA 08/2015 - 09/2013
2	AdiponectinIBA 01/2020 - 01/2018
2	SodiumIBA 01/2020 - 01/2018
2	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 01/2018
2	Antidepressive Agents (Antidepressants)IBA 01/2019 - 01/2019
2	CytokinesIBA 01/2019 - 01/2015
1	Diphosphonates (Bisphosphonates)IBA 03/2022
1	insulin receptor-related receptor (IRR)IBA 01/2022
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 11/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2021
1	Mineralocorticoid Receptor AntagonistsIBA 01/2021
1	PTX3 proteinIBA 11/2020
1	LactamsIBA 09/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 09/2020
1	beta-LactamsIBA 09/2020
1	Dihydrotachysterol (AT 10)IBA 07/2020
1	Infliximab (Remicade)FDA Link 07/2020
1	guselkumabIBA 07/2020
1	ixekizumabIBA 07/2020
1	risankizumabIBA 07/2020
1	Biological ProductsIBA 07/2020
1	secukinumabIBA 07/2020
1	Ustekinumab (CNTO 1275)FDA Link 07/2020
1	brodalumabIBA 07/2020
1	Adalimumab (Humira)FDA Link 07/2020
1	Timolol (Blocadren)FDA LinkGeneric 03/2020
1	Synthetic Prostaglandins (Prostaglandin Analogues)IBA 03/2020
1	IncretinsIBA 01/2020
1	Antihypertensive Agents (Antihypertensives)IBA 01/2020
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2020
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2020
1	beta-cyclodextrin tetradecasulfate (CTDS)IBA 03/2019
1	VaccinesIBA 01/2019
1	Progesterone FDA LinkGeneric 01/2019
1	Dydrogesterone FDA Link 01/2019
1	Estradiol (Delestrogen)FDA LinkGeneric 01/2019
1	Anticonvulsants (Antiepileptic Drugs)IBA 01/2019
1	HomocysteineIBA 01/2019

Therapy/Procedure

4	Therapeutics 01/2021 - 01/2018
2	Glycemic Control 01/2017 - 01/2017
2	Parenteral Nutrition 01/2015 - 01/2014
1	Lasers (Laser) 01/2022
1	Peritoneal Dialysis 01/2022
1	Prenatal Care (Care, Prenatal) 01/2022
1	Resistance Training 09/2021
1	Transplantation 10/2020